CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung Cancer. Kunihiro AG, Sarrett SM, Lastwika KJ, Solan JL, et al. J Nucl Med 2022 Apr 28. pii: jnumed.121.263511. doi: 10.2967/jnumed.121.263511.

Read + Share

Amedeo Smart

Independent Medical Education

Kunihiro AG, Sarrett SM, Lastwika KJ, Solan JL, et al. CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung Cancer. J Nucl Med 2022 Apr 28. pii: jnumed.121.263511. doi: 10.2967/jnumed.121.263511.
PMID: 35483965